On November 26, 2024 BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global oncology company that intends to change its name to BeOne Medicines Ltd., reported it will participate in fireside chats at two upcoming investor conferences (Press release, BeiGene, NOV 26, 2024, View Source [SID1234648651]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Citizens JMP Hematology and Oncology Summit on Monday, December 2 at 1:00 p.m. ET; and
Citi’s Global Healthcare Conference on Thursday, December 5 at 9:30 a.m. ET

The live webcasts of these events can be accessed from the investors section of BeiGene’s website at View Source, View Source, View Source An archived replay will be available for 90 days following the event.